LATIN- AMERICA (LA)+ Brain Initiative
Latin- America (LA)+ Brain Initiative is a regional chapter of SBMT’s Neuroscience20.
Topics: Neurosurgery, Neurology, Neuroradiology, Psychiatry, Neurotechnology, Neuroengineering, and related policies.
- Register for the N20 Summit
- About Neuroscience20
- About SBMT
- What is Brain Mapping
- SBMT President
- SBMT Board of Directors
Membership Services
Publications & Press
Social Media
Primer Congreso Internacional de Salud y Bienestar
Mexico | October 28-31, 2024
At the Primer Congreso Internacional de Salud y Bienestar en México, SBMT will showcase the latest advancements in brain mapping technologies and their potential to revolutionize the diagnosis and treatment of neurological disorders. By fostering collaboration between researchers, clinicians, and industry experts, SBMT aims to accelerate the translation of groundbreaking research into practical clinical applications, ultimately improving the lives of patients with neurological conditions.
Neuroscience20 - G20 Argentina 2018
Puerto Madero, Argentina | November 26-17, 2018
Neuroscience20 Argentina 2018 was a key global summit in Buenos Aires addressing brain, spine, and mental health disorders. It gathered leading neuroscientists, policymakers, and industry experts to discuss innovative neurotech solutions and advocate for global policies. The event highlighted the significant economic and human costs of these disorders. It led to the formation of the Neuroscience-20 (N20) Group, a consortium aimed at advancing neurotechnology and policy, along with consensus recommendations for G20 leaders.
1st Brain Mapping Day at the Brazilian Parliament
Brasilia, Brazil | July 2024
Society for Brain Mapping and Therapeutics (SBMT) hosted "Brain Mapping Day" at the Brazilian Parliament, gathering neuroscientists, policymakers, and industry leaders to discuss advancements in brain mapping for treating neurological disorders. SBMT aimed to educate lawmakers on neuroscience, fostering understanding and advocating for policies to enhance research and clinical applications. This initiative represents a significant step toward effectively diagnosing, treating, and preventing brain disorders.
